Literature DB >> 11095905

Lower Genital Tract Infections and HIV in Women.

.   

Abstract

Lower genital tract infections and HIV are major causes of morbidity and mortality among women; thier impact on the US economy amounts to several billion dollars each year. Most lower genital tract infections--and their adverse sequelae, such as pelvic inflammatory disease, ectopic pregnancy, chronic pelvic pain, and increased susceptibility to HIV--are caused by sexually transmitted diseases (STDs). This article reviews recent epidemiologic information relevant to some of the STDs that more commonly affect women, and recent advances in molecular biology, diagnostics, and treatments. Effective, consistent, and proper use of barrier contraception should be encouraged, to decrease the transmission of these infections.

Entities:  

Year:  2000        PMID: 11095905     DOI: 10.1007/s11908-000-0058-0

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN: 1523-3847            Impact factor:   3.725


  52 in total

1.  Seroprevalence of human papillomavirus type 16 in pregnant women.

Authors:  M E Hagensee; J Slavinsky; C M Gaffga; J Suros; P Kissinger; D H Martin
Journal:  Obstet Gynecol       Date:  1999-11       Impact factor: 7.661

2.  Increased interleukin-10 in the the endocervical secretions of women with non-ulcerative sexually transmitted diseases: a mechanism for enhanced HIV-1 transmission?

Authors:  C R Cohen; F A Plummer; N Mugo; I Maclean; C Shen; E A Bukusi; E Irungu; S Sinei; J Bwayo; R C Brunham
Journal:  AIDS       Date:  1999-02-25       Impact factor: 4.177

3.  Short fragment polymerase chain reaction reverse hybridization line probe assay to detect and genotype a broad spectrum of human papillomavirus types. Clinical evaluation and follow-up.

Authors:  W J Melchers; J M Bakkers; J Wang; P C de Wilde; H Boonstra; W G Quint; A G Hanselaar
Journal:  Am J Pathol       Date:  1999-11       Impact factor: 4.307

4.  The vagina has reducing environment sufficient for activation of Trichomonas vaginalis cysteine proteinases.

Authors:  J F Alderete; D Provenzano
Journal:  Genitourin Med       Date:  1997-08

5.  Bacterial vaginosis: a double-blind randomized trial of the effect of treatment of the sexual partner.

Authors:  M Vejtorp; A C Bollerup; L Vejtorp; E Fanøe; E Nathan; A Reiter; M E Andersen; B Strømsholt; S S Schrøder
Journal:  Br J Obstet Gynaecol       Date:  1988-09

6.  Clinical manifestations of genital infection due to Chlamydia trachomatis in women: differences related to serovar.

Authors:  K A Workowski; C E Stevens; R J Suchland; K K Holmes; D A Eschenbach; M B Pettinger; W E Stamm
Journal:  Clin Infect Dis       Date:  1994-10       Impact factor: 9.079

7.  Evaluation of seroreactivity to human papillomavirus type 16 virus-like particles in an incident case-control study of cervical neoplasia.

Authors:  L Wideroff; M H Schiffman; B Nonnenmacher; N Hubbert; R Kirnbauer; C E Greer; D Lowy; A T Lorincz; M M Manos; A G Glass
Journal:  J Infect Dis       Date:  1995-12       Impact factor: 5.226

8.  Demographic and behavioral predictors of Trichomonas vaginalis infection among pregnant women. The Vaginal Infections and Prematurity Study Group.

Authors:  M F Cotch; J G Pastorek; R P Nugent; D E Yerg; D H Martin; D A Eschenbach
Journal:  Obstet Gynecol       Date:  1991-12       Impact factor: 7.661

9.  Should male consorts of women with bacterial vaginosis be treated?

Authors:  H Moi; R Erkkola; F Jerve; G Nelleman; B Bymose; K Alaksen; E Tornqvist
Journal:  Genitourin Med       Date:  1989-08

10.  Hybrid Capture II-based human papillomavirus detection, a sensitive test to detect in routine high-grade cervical lesions: a preliminary study on 1518 women.

Authors:  C Clavel; M Masure; J P Bory; I Putaud; C Mangeonjean; M Lorenzato; R Gabriel; C Quereux; P Birembaut
Journal:  Br J Cancer       Date:  1999-07       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.